vs
ACV Auctions Inc.（ACVA）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是ACV Auctions Inc.的1.2倍（$219.9M vs $183.6M），ACV Auctions Inc.同比增速更快（15.1% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-14.7M），过去两年ACV Auctions Inc.的营收复合增速更高（12.3% vs 8.0%）
ACV Auctions Inc.是北美领先的数字化二手车批发拍卖平台，主要服务美加两地汽车经销商，提供车辆透明检测、安全支付、物流配送等全链条服务，助力注册批发买卖双方无需线下到场即可高效完成二手车交易。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ACVA vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$183.6M
营收增速更快
ACVA
高出13.2%
2.0%
自由现金流更多
OFIX
多$31.5M
$-14.7M
两年增速更快
ACVA
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.6M | $219.9M |
| 净利润 | — | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -9.7% | 0.2% |
| 净利率 | — | -1.0% |
| 营收同比 | 15.1% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $-0.12 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACVAOFIX
| Q4 25 | $183.6M | $219.9M | ||
| Q3 25 | $199.6M | $205.6M | ||
| Q2 25 | $193.7M | $203.1M | ||
| Q1 25 | $182.7M | $193.6M | ||
| Q4 24 | $159.5M | $215.7M | ||
| Q3 24 | $171.3M | $196.6M | ||
| Q2 24 | $160.6M | $198.6M | ||
| Q1 24 | $145.7M | $188.6M |
净利润ACVAOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-24.5M | $-22.8M | ||
| Q2 25 | $-7.3M | $-14.1M | ||
| Q1 25 | $-14.8M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $-16.0M | $-27.4M | ||
| Q2 24 | $-17.1M | $-33.4M | ||
| Q1 24 | $-20.5M | $-36.0M |
毛利率ACVAOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率ACVAOFIX
| Q4 25 | -9.7% | 0.2% | ||
| Q3 25 | -11.9% | -8.3% | ||
| Q2 25 | -3.7% | -7.9% | ||
| Q1 25 | -7.9% | -25.2% | ||
| Q4 24 | -16.2% | -5.3% | ||
| Q3 24 | -10.0% | -9.6% | ||
| Q2 24 | -11.6% | -12.5% | ||
| Q1 24 | -15.5% | -15.6% |
净利率ACVAOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | -12.3% | -11.1% | ||
| Q2 25 | -3.8% | -6.9% | ||
| Q1 25 | -8.1% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | -9.4% | -13.9% | ||
| Q2 24 | -10.6% | -16.8% | ||
| Q1 24 | -14.1% | -19.1% |
每股收益（稀释后）ACVAOFIX
| Q4 25 | $-0.12 | $-0.05 | ||
| Q3 25 | $-0.14 | $-0.57 | ||
| Q2 25 | $-0.04 | $-0.36 | ||
| Q1 25 | $-0.09 | $-1.35 | ||
| Q4 24 | $-0.15 | $-0.76 | ||
| Q3 24 | $-0.10 | $-0.71 | ||
| Q2 24 | $-0.10 | $-0.88 | ||
| Q1 24 | $-0.13 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $271.5M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $429.7M | $450.0M |
| 总资产 | $1.1B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACVAOFIX
| Q4 25 | $271.5M | $82.0M | ||
| Q3 25 | $265.3M | $62.9M | ||
| Q2 25 | $258.4M | $65.6M | ||
| Q1 25 | $291.9M | $58.0M | ||
| Q4 24 | $224.1M | $83.2M | ||
| Q3 24 | $252.5M | $30.1M | ||
| Q2 24 | $215.0M | $26.4M | ||
| Q1 24 | $209.8M | $27.0M |
总债务ACVAOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益ACVAOFIX
| Q4 25 | $429.7M | $450.0M | ||
| Q3 25 | $434.4M | $442.5M | ||
| Q2 25 | $448.8M | $458.3M | ||
| Q1 25 | $439.6M | $458.3M | ||
| Q4 24 | $440.0M | $503.1M | ||
| Q3 24 | $456.2M | $525.9M | ||
| Q2 24 | $457.6M | $546.0M | ||
| Q1 24 | $458.3M | $570.3M |
总资产ACVAOFIX
| Q4 25 | $1.1B | $850.6M | ||
| Q3 25 | $1.2B | $832.6M | ||
| Q2 25 | $1.1B | $837.2M | ||
| Q1 25 | $1.2B | $823.1M | ||
| Q4 24 | $984.1M | $893.3M | ||
| Q3 24 | $1.0B | $867.9M | ||
| Q2 24 | $1.0B | $882.0M | ||
| Q1 24 | $1.0B | $906.0M |
负债/权益比ACVAOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-14.7M | $16.8M |
| 自由现金流率自由现金流/营收 | -8.0% | 7.6% |
| 资本支出强度资本支出/营收 | 1.2% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $69.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ACVAOFIX
| Q4 25 | $-12.4M | $27.7M | ||
| Q3 25 | $10.3M | $12.4M | ||
| Q2 25 | $13.7M | $11.6M | ||
| Q1 25 | $66.6M | $-18.4M | ||
| Q4 24 | $-3.2M | $23.7M | ||
| Q3 24 | $21.1M | $11.7M | ||
| Q2 24 | $4.5M | $9.0M | ||
| Q1 24 | $43.0M | $-18.6M |
自由现金流ACVAOFIX
| Q4 25 | $-14.7M | $16.8M | ||
| Q3 25 | $7.7M | $2.5M | ||
| Q2 25 | $10.9M | $4.5M | ||
| Q1 25 | $65.3M | $-25.1M | ||
| Q4 24 | $-3.9M | $15.2M | ||
| Q3 24 | $20.2M | $6.3M | ||
| Q2 24 | $2.7M | $-360.0K | ||
| Q1 24 | $41.9M | $-29.1M |
自由现金流率ACVAOFIX
| Q4 25 | -8.0% | 7.6% | ||
| Q3 25 | 3.8% | 1.2% | ||
| Q2 25 | 5.6% | 2.2% | ||
| Q1 25 | 35.7% | -13.0% | ||
| Q4 24 | -2.5% | 7.0% | ||
| Q3 24 | 11.8% | 3.2% | ||
| Q2 24 | 1.7% | -0.2% | ||
| Q1 24 | 28.8% | -15.4% |
资本支出强度ACVAOFIX
| Q4 25 | 1.2% | 4.9% | ||
| Q3 25 | 1.3% | 4.8% | ||
| Q2 25 | 1.5% | 3.5% | ||
| Q1 25 | 0.7% | 3.5% | ||
| Q4 24 | 0.4% | 4.0% | ||
| Q3 24 | 0.6% | 2.7% | ||
| Q2 24 | 1.1% | 4.7% | ||
| Q1 24 | 0.7% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACVA
| Auction Marketplace Revenue | $77.6M | 42% |
| Other Marketplace Revenue | $72.4M | 39% |
| Customer Assurance | $24.1M | 13% |
| Data Services Revenue | $9.4M | 5% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
